4-Oxo-3,4-dihydroquinazoline-8-carboxylic acid
CAS : 19181-77-2
Ref. 3D-UAA18177
| 1g | Arrêté | ||
| 5g | Arrêté | ||
| 100mg | Arrêté | ||
| 250mg | Arrêté | ||
| 500mg | Arrêté |
Informations sur le produit
Nom :
4-Oxo-3,4-dihydroquinazoline-8-carboxylic acid
Description :
4-Oxo-3,4-dihydroquinazoline-8-carboxylic acid is a synthetic compound that has shown to have anti-cancer properties. It inhibits the activity of b-raf and is active against mutant melanoma cells. The drug has low solubility in water and therefore requires an organic solvent for administration. 4ODQCA has a short half life in vivo and is excreted by the kidney. Its pharmacokinetic properties are determined by its physicochemical profile, which includes molecular weight, lipophilicity, and logP value. These characteristics allow it to diffuse across cell membranes through passive transport mechanisms.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
190.16 g/mol
Formule :
C9H6N2O3
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
